We are live on ! Find out more
AA

AQR Arbitrage Portfolio holdings

AUM $6.09B
1-Year Est. Return 27.01%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+27.01%
3 Year Est. Return
+77.25%
5 Year Est. Return
+160.09%
10 Year Est. Return
+1,244.43%
AUM
$2.78B
AUM Growth
-$65.9M
Cap. Flow
-$1.1B
Cap. Flow %
-39.55%
Top 10 Hldgs %
16.2%
Holding
1,575
New
503
Increased
22
Reduced
219
Closed
602

Sector Composition

Rank Sector Weight
1 Financials 10.51%
2 Healthcare 6.47%
3 Industrials 4.82%
4 Consumer Discretionary 4.5%
5 Technology 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COVAU
451
DELISTED
COVA Acquisition Corp. Unit
COVAU
$528K 0.02%
+53,100
New +$546K
NAACU
452
DELISTED
North Atlantic Acquisition Corporation Unit
NAACU
$527K 0.02%
+53,000
New +$544K
BIOTU
453
DELISTED
Biotech Acquisition Company Unit
BIOTU
$524K 0.02%
+53,000
New +$545K
EPHY
454
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$524K 0.02%
+53,748
New +$529K
ASTRW
455
DELISTED
Astra Space, Inc. Warrant
ASTRW
$522K 0.02%
180,666
ITAC
456
DELISTED
Industrial Tech Acquisitions, Inc. Class A common stock
ITAC
$522K 0.02%
52,078
-198,922
-79% -$2.03M
FCAX
457
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$520K 0.02%
+52,995
New +$523K
AURCU
458
DELISTED
Aurora Acquisition Corp. Unit
AURCU
$518K 0.02%
+50,000
New +$505K
FOXWU
459
DELISTED
FoxWayne Enterprises Acquisition Corp. Unit
FOXWU
$518K 0.02%
+50,000
New +$521K
AEVAW
460
DELISTED
Aeva Technologies Warrants
AEVAW
$517K 0.02%
+155,707
New +$657K
PNTM
461
DELISTED
Pontem Corporation
PNTM
$513K 0.02%
+52,998
New +$516K
JRS icon
462
Nuveen Real Estate Income Fund
JRS
$251M
$508K 0.02%
52,940
-61,398
-54% -$547K
LMAOU
463
DELISTED
LMF Acquisition Opportunities Inc. Unit
LMAOU
$508K 0.02%
+50,000
New +$514K
DGNU
464
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$506K 0.02%
+50,000
New +$505K
CII icon
465
BlackRock Enhanced Captial and Income Fund
CII
$984M
$504K 0.02%
26,116
-53,124
-67% -$975K
FTAAU
466
DELISTED
FTAC Athena Acquisition Corp. Unit
FTAAU
$503K 0.02%
+50,000
New +$517K
THBRW
467
DELISTED
Thunder Bridge Acquisition II, Ltd. Warrants
THBRW
$503K 0.02%
229,696
-270,304
-54% -$782K
ITHXU
468
DELISTED
ITHAX Acquisition Corp. Unit
ITHXU
$502K 0.02%
+50,000
New +$507K
SNII.U
469
DELISTED
Supernova Partners Acquisition Company II, Ltd. Units, each consisting of one Class A ordinary share
SNII.U
$502K 0.02%
+50,000
New +$506K
RTPYU
470
DELISTED
Reinvent Technology Partners Y Unit
RTPYU
$502K 0.02%
+50,000
New +$503K
RKTA.U
471
DELISTED
Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RKTA.U
$501K 0.02%
+50,000
New +$501K
IGNYU
472
DELISTED
Ignyte Acquisition Corp. Unit
IGNYU
$501K 0.02%
+50,000
New +$517K
PPGHU
473
DELISTED
Poema Global Holdings Corp. Unit
PPGHU
$501K 0.02%
+50,000
New +$522K
PRPC.U
474
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
$500K 0.02%
+50,000
New +$516K
LGACU
475
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
$500K 0.02%
+50,000
New +$509K

Similar funds

AQR Arbitrage's Q1 2021 Portfolio in Review

As of Q1 2021, AQR Arbitrage held 1,575 positions worth $2.78B, down 2.3% from $2.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AQR Arbitrage withdrew a net $1.1B in Q1 2021, closing 602 positions and reducing 219 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $36.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AQR Arbitrage opened a new position in Cantel Medical Corporation worth $33.4M.

  • AQR Arbitrage's largest Q1 2021 buy was Cantel Medical Corporation: 420,838 shares worth $33.4M.
  • AQR Arbitrage added most to PRA Health Sciences, Inc. in Q1 2021, an estimated $23.3M increase.
  • AQR Arbitrage's biggest Q1 2021 reduction was International Flavors & Fragrances Inc. 6.00% Tangible Equity Units, cutting an estimated $12.5M.
  • AQR Arbitrage fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $36.2M.
  • AQR Arbitrage's ten largest holdings make up 16% of its $2.78B portfolio in Q1 2021.
  • AQR Arbitrage opened 503 new positions and closed 602 in Q1 2021.
  • AQR Arbitrage's portfolio value fell 2.3% quarter-over-quarter to $2.78B.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.